These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33562622)

  • 21. Organoiridium complexes: anticancer agents and catalysts.
    Liu Z; Sadler PJ
    Acc Chem Res; 2014 Apr; 47(4):1174-85. PubMed ID: 24555658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
    Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
    Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F
    Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies.
    Bhattacharyya S; Purkait K; Mukherjee A
    Dalton Trans; 2017 Jul; 46(26):8539-8554. PubMed ID: 28638907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivity.
    Dömötör O; Aicher S; Schmidlehner M; Novak MS; Roller A; Jakupec MA; Kandioller W; Hartinger CG; Keppler BK; Enyedy ÉA
    J Inorg Biochem; 2014 May; 134():57-65. PubMed ID: 24556426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved antiparasitic activity by incorporation of organosilane entities into half-sandwich ruthenium(II) and rhodium(III) thiosemicarbazone complexes.
    Adams M; de Kock C; Smith PJ; Land KM; Liu N; Hopper M; Hsiao A; Burgoyne AR; Stringer T; Meyer M; Wiesner L; Chibale K; Smith GS
    Dalton Trans; 2015 Feb; 44(5):2456-68. PubMed ID: 25559246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
    Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity.
    Fu Y; Habtemariam A; Basri AM; Braddick D; Clarkson GJ; Sadler PJ
    Dalton Trans; 2011 Oct; 40(40):10553-62. PubMed ID: 21860862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metal-Dependent Cytotoxic and Kinesin Spindle Protein Inhibitory Activity of Ru, Os, Rh, and Ir Half-Sandwich Complexes of Ispinesib-Derived Ligands.
    Łomzik M; Hanif M; Budniok A; Błauż A; Makal A; Tchoń DM; Leśniewska B; Tong KKH; Movassaghi S; Söhnel T; Jamieson SMF; Zafar A; Reynisson J; Rychlik B; Hartinger CG; Plażuk D
    Inorg Chem; 2020 Oct; 59(20):14879-14890. PubMed ID: 33003697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and structural characterization of binuclear half-sandwich iridium, rhodium and ruthenium complexes containing 4,4'-dipyridyldisulfide (4DPDS) ligands.
    Han YF; Li H; Fei Y; Lin YJ; Zhang WZ; Jin GX
    Dalton Trans; 2010 Aug; 39(30):7119-24. PubMed ID: 20593103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Group 9 organometallic compounds for therapeutic and bioanalytical applications.
    Ma DL; Chan DS; Leung CH
    Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addition of ethynylferrocene to transition-metal complexes containing a chelating 1,2-dicarba-closo-dodecaborane-1,2-dichalcogenolate ligand--in vitro cooperativity of a ruthenium compound on cellular uptake of an anticancer drug.
    Wu DH; Wu CH; Li YZ; Guo DD; Wang XM; Yan H
    Dalton Trans; 2009 Jan; (2):285-90. PubMed ID: 19089009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
    Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
    Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CF3 Derivatives of the Anticancer Ru(III) Complexes KP1019, NKP-1339, and Their Imidazole and Pyridine Analogues Show Enhanced Lipophilicity, Albumin Interactions, and Cytotoxicity.
    Chang SW; Lewis AR; Prosser KE; Thompson JR; Gladkikh M; Bally MB; Warren JJ; Walsby CJ
    Inorg Chem; 2016 May; 55(10):4850-63. PubMed ID: 27143338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Similarities and differences in d
    Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E
    J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin.
    Meier SM; Kreutz D; Winter L; Klose MHM; Cseh K; Weiss T; Bileck A; Alte B; Mader JC; Jana S; Chatterjee A; Bhattacharyya A; Hejl M; Jakupec MA; Heffeter P; Berger W; Hartinger CG; Keppler BK; Wiche G; Gerner C
    Angew Chem Int Ed Engl; 2017 Jul; 56(28):8267-8271. PubMed ID: 28547791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulating the anticancer properties of organometallic dendrimers using pyridylferrocene entities: synthesis, cytotoxicity and DNA binding studies.
    Govender P; Riedel T; Dyson PJ; Smith GS
    Dalton Trans; 2016 Jun; 45(23):9529-39. PubMed ID: 27193373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro.
    Kandioller W; Hartinger CG; Nazarov AA; Bartel C; Skocic M; Jakupec MA; Arion VB; Keppler BK
    Chemistry; 2009 Nov; 15(45):12283-91. PubMed ID: 19821465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
    Ruiz J; Vicente C; de Haro C; Bautista D
    Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticancer activity of tetracationic arene ruthenium metalla-cycles.
    Barry NP; Edafe F; Therrien B
    Dalton Trans; 2011 Jul; 40(27):7172-80. PubMed ID: 21660364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.